Stryker and CMR Surgical announce strategic alliance for Versius robotic surgery

Stryker has made a $400 million preferred equity investment in CMR Surgical, with an exclusive option to acquire the company. Stryker will serve as the exclusive U.S. sales agent for CMR Surgical's Versius robotic surgery portfolio.

“Stryker will make an approximately $400 million (£300 million) preferred equity investment in CMR Surgical to support future innovation and global commercialization of the Versius portfolio, subject to customary closing conditions.”stryker.com

• 1 source
• stryker.comStryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery | StrykerOct 12, 2026

Summarized from public sources; check the original articles before acting on it.